Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CBD Pharmacokinetics”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Early research (Phase 1)Study completedNCT03091868
What this trial is testing

Pharmacokinetics of Rising Single-doses of BIA 6-512 and Their Effect on the Levodopa Pharmacokinetics

Who this might be right for
Parkinson Disease
Bial - Portela C S.A. 80
Early research (Phase 1)Study completedNCT06648031
What this trial is testing

Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants

Who this might be right for
Type2diabetes
Lexaria Bioscience Corp. 148
Early research (Phase 1)Study completedNCT02286986
What this trial is testing

Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy

Who this might be right for
Epilepsy
University of Utah 26
Post-approval studies (Phase 4)Study completedNCT00906828
What this trial is testing

Pharmacokinetics of Levodopa/Carbidopa Infusion With and Without Oral Catechol-O-methyl Transferase (COMT) Inhibitors

Who this might be right for
Parkinson Disease
Uppsala University 10
Early research (Phase 1)Study completedNCT06578455
What this trial is testing

A Pharmacokinetic Study to Compare CBD-NE to Epidyolex in Healthy Adult Volunteers Under Both Fed and Fasted Conditions

Who this might be right for
CBD PharmacokineticsHealthy Participants
dsm-firmenich Switzerland AG 32
Early research (Phase 1)Study completedNCT02116465
What this trial is testing

Pharmacokinetic Study With Levodopa-carbidopa Fixed-dose Products in Healthy Subjects After Oral Administration

Who this might be right for
Fasted State
Desitin Arzneimittel GmbH 12
Large-scale testing (Phase 3)Ended earlyNCT04485104
What this trial is testing

Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures

Who this might be right for
Seizure in Participants With Tuberous Sclerosis ComplexSeizure in Participants With Dravet SyndromeSeizure in Participants With Lennox-Gastaut Syndrome
Jazz Pharmaceuticals 3
Not applicableWithdrawnNCT02910297
What this trial is testing

The Pharmacokinetics of Cannabidiol (CBD) and Its Effects in Children With Severe Epilepsy

Who this might be right for
Dravet SyndromeLennox Gastaut Syndrome
Gillette Children's Specialty Healthcare
Early research (Phase 1)Study completedNCT01893424
What this trial is testing

Bioequivalence Assessment of Oral Administration Vs. Oral Spray of a Cannabinoids (Tetrahydrocannabinol and Cannabidiol)

Who this might be right for
Pain
Hadassah Medical Organization 12
Very early researchUnknownNCT03877991
What this trial is testing

Bioequivalence Assessment of Cannabidiol (CBD) Administrated in Oral Formulations

Who this might be right for
Pain
Hadassah Medical Organization 12
Early research (Phase 1)Study completedNCT01519284
What this trial is testing

Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic

Who this might be right for
Parkinson Disease
Bial - Portela C S.A. 82
Very early researchActive Not RecruitingNCT04878627
What this trial is testing

Role of CBD in Regulating Meal Time Anxiety in Anorexia Nervosa

Who this might be right for
Anorexia Nervosa
University of California, San Diego 40
Early research (Phase 1)Study completedNCT02096601
What this trial is testing

A Safety, Tolerability, and Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
NeuroDerm Ltd. 16
Very early researchLooking for participantsNCT06692933
What this trial is testing

Effects of a Hemp Product on the Pharmacokinetics and Pharmacodynamics of Clopidogrel

Who this might be right for
Interaction
Washington State University 24
Early research (Phase 1)Study completedNCT02312232
What this trial is testing

Pharmacokinetic Study in Healthy Males

Who this might be right for
Parkinson's Disease
Orion Corporation, Orion Pharma 20
Testing effectiveness (Phase 2)Study completedNCT01479127
What this trial is testing

Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease

Who this might be right for
Advanced Parkinson's Disease
AbbVie (prior sponsor, Abbott) 8
Early research (Phase 1)Looking for participantsNCT05067387
What this trial is testing

Evaluation of Oral THC and CBD in Men and Women

Who this might be right for
Drug AbuseIntoxication by DrugImpairment
University of California, Los Angeles 22
Early research (Phase 1)Study completedNCT01887301
What this trial is testing

Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients

Who this might be right for
Hepatic Impairment
Jazz Pharmaceuticals 32
Early research (Phase 1)Study completedNCT02554734
What this trial is testing

Pharmacokinetic Study in Healthy Volunteers

Who this might be right for
Parkinson's Disease
Orion Corporation, Orion Pharma 15
Testing effectiveness (Phase 2)Study completedNCT01026428
What this trial is testing

Assess the Effect of Safinamide on Levodopa Pharmacokinetics

Who this might be right for
Idiopathic Parkinson's Disease
Newron Pharmaceuticals SPA 24
Next Page